NASDAQ
Matinas BioPharma Holdings, Inc. (MTNB) has a revenue compound annual growth rate of 55.71% over 5 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.